Republicans are constantly advancing proposals that would limit the voting rights of populations known to vote Democratic. He’s just giving the ball another spin.
Besides, he believes in going back to the original constitution. All those amendments are woke. We can just get rid of them. Now that he’s had a run-in with Nikki Haley - mocking her for her native first name of all things - I’m sure the 19th Amendment is the next to go.
Not only would it suppress the vote of young people, it would also silence the disabled, many women, and others who can not meet the physical requirements of being in the military or a first responder. The “out” of passing the same test as immigrants seeking to be naturalized seems an answer to that except if you’re born here citizenship is supposed to be automatic (by constitution) and this is essentially saying if you aren’t military or first responder you’re not really a full citizen.
Sounds like someone has been reading too much Starship Troopers, among other things.,
Conservatives have this weird attitude towards names, being very concerned if it looks like someone changed their name to appear less ethnic, or in the case of trans people, being something else. They also tend to have strong notions about what names should be, so for example they might get really lathered about a married woman keeping her birth name instead of changing her surname to match her husband (presuming “traditional” man-woman marriage, of course).
As he calls her a liar in more or less the same breathe, I do believe the implication is that she’s a liar even starting with her name, so nothing she says can be trusted. Nevermind that it’s her maiden name and she took her husband’s surname like a proper conservative women, and that Nikki was part of her birth name and like many other people she prefers to go by her second/middle name with not a whiff of fraud about it.
“During a campaign stop in Iowa last weekend, Ramaswamy said, “I’m clear, we will defend Taiwan, at least until we have achieved semiconductor independence in this country, at which point we will reevaluate.””
The US will not achieve semiconductor independence. The Chips Act is a sneeze at the problem, if you want to call it a national security problem. I don’t think that all Americans want to pay 40% more than what they are paying today for electronics and other items that include semiconductor chips. TSMC, who has announced a new factory in Arizona, probably will not finish its construction, labor costs compared to other facilities throughout Asia are astronomical and just don’t make it practically feasible, unless the US mandated a “buy America” for any uses of semiconductors in the US or imposed massive tariffs on imported chips.
I first “met” him during his interview with Kaitlan Collins on CNN the evening before the debate. He came across as so insincere, so condescending, and, yes, so smarmy. He spoke to the very capable Collins as if she were a child.
And then he did nothing to shake that impression during the debate.
For those still struggling to find the electoral love for this guy … I give you …
The sordid details are all but irrelevant. They’re also all but original. He’s just doubling down on a patented Trump move: I’m far too busy to deal with the problems of common men.
Screw it, let’s call his bluff: Pass a law to make everyone pass a civics exam to be allowed to vote.
I’m sure he’s just self-aware enough to know that the Republican base will end up with the short end of the stick on that. No matter how dumbed-down the test is.
It’s the Bizzaro Universe equivalent of how they always referred to “Barrack HUSSEIN Obama”, or “Barry Soetoro”. Talking about face-eating, I’m surprised Haley didn’t see this coming, it’s standard operating procedure for Republicans.
I’ve often asked this question, but I’ll try again.
Does he really believe this stuff, or is it the preferred Republican method to run a political campaign on insult, exaggeration and lies?
Actually I don’t think it would have. Phase three trials are frigging expensive and so the only reason that anyone is going to run one is the they are a company hoping to use that trial as a basis for getting their drug approved by the FDA. So generally you would expect the people who run the trial and publish the paper to be affiliated with the company who makes the drug.
But just because they run the trial doesn’t mean that they just waltz in, fake the data, and lie with statistics to get the answer they want. The conducting of phase three trials has extremely strong oversight by every aspect of it from patient selection to final analysis methodology has to be laid out in rigorous detail and approved NIH and the FDA before its allowed to start, This may involve a lot of wrangling as the company wants it to be done one way but the FDA says it has to be done another way. They also have to be careful how they design it. They might want to have fewer patients to save money, but then that might make it harder to see an effect. They might want to cherry pick a class of patients where they think their drug will be most effective (say those with most severe disease) but then it will only be approved for that cherry picked class. etc.
During the trial all aspects of it are carefully monitored by an independent agency to make sure that there is no funny buisness going on, and if they every deviate from what they said they were going to do they must have a damn good reason along with an explanation of how they will account for this breech of protocol in their final analysis.
Then finally, at the end no matter what the results of the trial are, those results have to be published, including the prescribed statistical analyses. You can’t look at the data realize it makes you look bad and cover the whole thing up. That is why the very specific language “did not produce statistical improvement over placebo on cognition or activities of daily living in mild-to-moderate AD dementia patients.” was included, because that was precisely what the trial was designed to test on on whom it was tested, and if they didn’t word it pretty much exactly that way the FDA would come down on them like a ton of bricks.
TLDR: Having people from the company as main authors on the paper is standard practice and nothing to worry about.
If you’re acting in the best interest of the company, yes. It’s not inconceivable that a person within the company might approve a trial with the hope that the publicity will keep the stock price high, and then sell their stock before the results of the trial are released.
I’m not saying that did happen, and I hope the company and the law would take steps to prevent it, but the incentive is there.
There’s a thing called a blackout period during which company insiders aren’t supposed to buy or sell stock in their company. This seems to apply primarily to preknowledge of earnings reports before their public release, so I don’t know if it would apply to foreknowledge of clinical trial outcomes.